Skip to content
Review

Significant Advances in Research on Drug-Drug Interactions in the Past Five Years

Sep 2026 · Current Bioinformatics · 0 citations

TL;DR

This review systematically analyzes key challenges in DDI prediction: balancing model performance with interpretability, integrating heterogeneous features, ensuring sample set reliability, and optimizing algorithmic architectures, and outlines promising directions for future innovation.

Abstract

Drug–Drug Interaction (DDI) prediction is pivotal in pharmaceutical research and clinical practice, enhancing medication safety and optimizing therapeutic strategies. Traditional experimental approaches, constrained by high costs and time consumption, are insufficient for large-scale screening. Consequently, computational prediction methods have garnered increasing attention. This review systematically analyzes key challenges in DDI prediction: balancing model performance with interpretability, integrating heterogeneous features, ensuring sample set reliability, and optimizing algorithmic architectures. Database resources are categorized into drug interaction databases (e.g., DrugBank), compound feature databases (e.g., PubChem), and protein-related databases (e.g., UniProt). Four primary feature encoding strategies are examined: pre-trained language model representations, multimodal fusion encoding, chemical structure-based encoding, and knowledge graphbased encoding. Mainstream DDI prediction approaches are classified into five paradigms: traditional machine learning, deep learning, graph neural networks, knowledge graph-based methods, and contrastive learning approaches. Empirical results from benchmark datasets demonstrate that deep learning models integrating multi-scale features and attention mechanisms (e.g., MSDF) achieve superior predictive accuracy, while graph neural networks (e.g., GCN-BMP) excel at capturing complex relational structures. This review provides a robust reference for methodological selection and outlines promising directions for future innovation in DDI prediction, offering valuable guidance for advancing drug safety evaluation in precision medicine.

View source

Similar papers

Sep 2026

Deep Learning Protocols for Predicting Drug Mechanism of Action and Drug-Target Interactions.

Two deep learning-based computational protocols designed to address drug mechanisms of action and predicting drug-target interactions are presented, offering scalable, cost-effective tools for accelerating therapeutic development by bridging chemical structure, molecular interactions, and systems-level biological respo...

Y. Sun, Cheng-You Liu, Zi-Hao Jing et al. · 0 citations
Review Sep 2026

Precision Drug Discovery in the Era of Artificial Intelligence: A Critical Review.

A paradigm shift toward autonomous scientific agents capable of causal reasoning and end-to-end experimental guidance is highlighted, and persistent challenges are discussed, including data bias, limited interpretability, and in silico-to-wet lab translation.

Meng Liu, Jia-Cheng Xiong, Ming-Yue Zheng · 1 citation
Conference Open access 2026

Advances in the Application of Machine Learning and Deep Learning in Drug–Drug Interaction Prediction

The current application status of artificial intelligence in DDI prediction can promote existing pharmacological theories and provide practical references for clinical medication, which can promote existing pharmacological theories and provide practical references for clinical medication.

Jun-Ru Lu · 0 citations
Review Open access Sep 2026

Drug–Drug Interaction Prediction: Aligning Evidence, Models, Validation, and Clinical Use

A claim-centered framework is introduced that clarifies which claims current DDI benchmarks can support and what additional evidence is needed before predictions can guide prescribing or monitoring and shows that useful explanations require evidence alignment and actionability in addition to visual plausibility.

Jing-Xiang Yang · 0 citations
Review Aug 2026

Artificial Intelligence in Druggable Protein Identification: Data-driven Multidimensional Representations and the Evolution of Predictive Models.

This review systematically summarizes the latest research progress in druggable protein prediction algorithms, providing a comprehensive analysis across three dimensions: data resources, feature engineering, and predictive models.

Hong-Qi Zhang, Hong-Ling Wang, Shang-Hua Liu et al. · 0 citations
Review Aug 2026

Harnessing the Power of AI: A Modern Review on the Prediction of ADMET Properties in Drug Discovery.

Artificial intelligence-driven ADMET prediction is becoming a vital tool in lowering attrition, speeding up candidate prioritization, and influencing the direction of rational drug development, despite persistent issues with data quality, regulatory acceptance, and synthetic viability.

Satyam Kumar Vishwash, Ram Babu Soni, Ratima Sood et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.